The U.S. Food and Drug Administration has approved its first opioid reversal drug, Narcan, for over-the-counter, nonprescription use. "Today's action paves the way for the life-saving medication to reverse an opioid overdose to be sold directly to consumers in places like drug stores, convenience stores, grocery stores and gas stations, as well as online." U.S. Food and Drug Administration Narcan, the brand name of the nasal spray naloxone, will switch from prescription to over-the-counter status within the next several months, the agency said. Prescriptions will still be required for other formulations and dosages of naloxone.